| abstract |
The following compounds of formula (I), pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing, are disclosed. It also discloses a pharmaceutical composition comprising such a compound, a method for treating cystic fibrosis using such a compound, and a method of preparing such a compound. |